View in EDS HTML Full Text PDF Full Text

Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.

Saved in:
Bibliographic Details
Title: Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
Authors: Prentice RE; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Tjandra D; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Garg M; Department of Gastroenterology, Northern Hospital and University of Melbourne, Melbourne, VIC, Australia., Lubel JS; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, VIC, Australia., Fourlanos S; Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Johnson D; Victorian Infectious Diseases Unit, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Al-Ani A; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Christensen B; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Oct; Vol. 52 (8), pp. 1422-1423.
Publication Type: Letter; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33105980
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Prentice+RE%22">Prentice RE</searchLink>; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Tjandra+D%22">Tjandra D</searchLink>; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Garg+M%22">Garg M</searchLink>; Department of Gastroenterology, Northern Hospital and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lubel+JS%22">Lubel JS</searchLink>; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Fourlanos+S%22">Fourlanos S</searchLink>; Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Johnson+D%22">Johnson D</searchLink>; Victorian Infectious Diseases Unit, The Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Al-Ani+A%22">Al-Ani A</searchLink>; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Christensen+B%22">Christensen B</searchLink>; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2020 Oct; Vol. 52 (8), pp. 1422-1423.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2036 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33105980
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/apt.16063
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1422
    Titles:
      – TitleFull: Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Prentice RE
      – PersonEntity:
          Name:
            NameFull: Tjandra D
      – PersonEntity:
          Name:
            NameFull: Garg M
      – PersonEntity:
          Name:
            NameFull: Lubel JS
      – PersonEntity:
          Name:
            NameFull: Fourlanos S
      – PersonEntity:
          Name:
            NameFull: Johnson D
      – PersonEntity:
          Name:
            NameFull: Al-Ani A
      – PersonEntity:
          Name:
            NameFull: Christensen B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2020 Oct
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2036
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Alimentary pharmacology & therapeutics
              Type: main
ResultId 1